Blast crisis of chronic myeloid leukaemia
Leukaemia · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Transformation of chronic myeloid leukaemia to acute leukaemia with more than 20% blasts, causing marrow failure, leukostasis and rapid clinical deterioration.
Red flags
- Leukostasis (breathlessness, confusion, priapism)
- Tumour lysis syndrome
- DIC / bleeding
- Very high blast count
Assessment
Differential diagnosis
- De novo acute leukaemia
- Accelerated phase CML
- Leukemoid reaction
- Leukostasis (other)
- Myelofibrosis
Investigations
- FBC and blood film (blasts)
- U&E, urate, LDH, phosphate, calcium (tumour lysis)
- Coagulation / DIC screen
- Bone marrow and cytogenetics
- Assess for leukostasis (CNS, pulmonary)
Management
- Assess for leukostasis, tumour lysis and DIC
- Aggressive hydration and tumour lysis prophylaxis
- Urgent haematology referral
- Supportive care and transfusion as needed
- Start disease-directed therapy per specialist
- Consider leukapheresis for symptomatic leukostasis
Drugs & doses
IV fluids and rasburicase / allopurinol for tumour lysis
Tyrosine kinase inhibitor +/- chemotherapy (specialist)
Blood product support
Disposition
Admit; urgent haematology.
Complications & pitfalls
- Leukostasis
- Tumour lysis syndrome
- DIC
- Marrow failure
Exam pearls
- Blast crisis may be the first presentation of previously undiagnosed CML.
- Anticipate and prevent tumour lysis before starting therapy.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.